Get started
HERON THERAPEUTICS INC COM USD0.01HERON THERAPEUTICS INC COM USD0.01HERON THERAPEUTICS INC COM USD0.01

HERON THERAPEUTICS INC COM USD0.01

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

0J4V chart


Full chart

Key facts today


Heron Therapeutics appointed Mark Hensley as its chief operating officer; Hensley previously served as CEO of Veloxis Pharmaceuticals from 2021 to 2024.
Analyze the impactAnalyze the impact

0J4V upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪354.93 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.08 USD
Net income (FY)
‪−13.58 M‬ USD
Revenue (FY)
‪144.28 M‬ USD
Shares float
‪150.92 M‬
Beta (1Y)
1.09

Employees


Employees (FY)
122
Change (1Y)
−4 −3.17%
Revenue / Employee (1Y)
‪1.18 M‬ USD
Net income / Employee (1Y)
‪−111.31 K‬ USD

About Heron Therapeutics, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Craig A. Collard
Website
herontx.com
Headquarters
Cary
Founded
1983
FIGI
BBG00JVXD337
Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in Cary, NC.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

0J4V news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as 0J4V.

Frequently Asked Questions


The current price of 0J4V is 2.34 USD — it has decreased by −2.59% in the past 24 hours. Watch HERON THERAPEUTICS INC COM USD0.01 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange HERON THERAPEUTICS INC COM USD0.01 stocks are traded under the ticker 0J4V.
0J4V stock has risen by 18.68% compared to the previous week, the month change is a −2.13% fall, over the last year HERON THERAPEUTICS INC COM USD0.01 has showed a −4.88% decrease.
We've gathered analysts' opinions on HERON THERAPEUTICS INC COM USD0.01 future price: according to them, 0J4V price has a max estimate of 9.00 USD and a min estimate of 4.00 USD. Watch 0J4V chart and read a more detailed HERON THERAPEUTICS INC COM USD0.01 stock forecast: see what analysts think of HERON THERAPEUTICS INC COM USD0.01 and suggest that you do with its stocks.
0J4V reached its all-time high on Jul 9, 2018 with the price of 41.16 USD, and its all-time low was 0.56 USD and was reached on Nov 10, 2023. View more price dynamics on 0J4V chart.
See other stocks reaching their highest and lowest prices.
0J4V stock is 3.63% volatile and has beta coefficient of 1.09. Track HERON THERAPEUTICS INC COM USD0.01 stock price on the chart and check out the list of the most volatile stocks — is HERON THERAPEUTICS INC COM USD0.01 there?
Today HERON THERAPEUTICS INC COM USD0.01 has the market capitalization of ‪354.93 M‬, it has increased by 8.37% over the last week.
Yes, you can track HERON THERAPEUTICS INC COM USD0.01 financials in yearly and quarterly reports right on TradingView.
HERON THERAPEUTICS INC COM USD0.01 is going to release the next earnings report on May 6, 2025. Keep track of upcoming events with our Earnings Calendar.
0J4V earnings for the last quarter are 0.02 USD per share, whereas the estimation was −0.031 USD resulting in a 165.47% surprise. The estimated earnings for the next quarter are −0.0062 USD per share. See more details about HERON THERAPEUTICS INC COM USD0.01 earnings.
HERON THERAPEUTICS INC COM USD0.01 revenue for the last quarter amounts to ‪40.78 M‬ USD, despite the estimated figure of ‪37.29 M‬ USD. In the next quarter, revenue is expected to reach ‪37.43 M‬ USD.
0J4V net income for the last quarter is ‪3.66 M‬ USD, while the quarter before that showed ‪−4.85 M‬ USD of net income which accounts for 175.56% change. Track more HERON THERAPEUTICS INC COM USD0.01 financial stats to get the full picture.
No, 0J4V doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 30, 2025, the company has 122 employees. See our rating of the largest employees — is HERON THERAPEUTICS INC COM USD0.01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HERON THERAPEUTICS INC COM USD0.01 EBITDA is ‪−9.04 M‬ USD, and current EBITDA margin is −6.26%. See more stats in HERON THERAPEUTICS INC COM USD0.01 financial statements.
Like other stocks, 0J4V shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HERON THERAPEUTICS INC COM USD0.01 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HERON THERAPEUTICS INC COM USD0.01 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HERON THERAPEUTICS INC COM USD0.01 stock shows the buy signal. See more of HERON THERAPEUTICS INC COM USD0.01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.